VISIFIRM™ vs. StriVectin-SD?
Visifirm's
Self-Activating and Patented Technology Smoothes Away the Appearance of Deep Wrinkles while delivering Tri-Peptide technology to visibly firm the skin and smooth away deep wrinkles.
- Reduce area of deep wrinkles by
44%
- Reduce depth of main wrinkles by 39%
- Reduce overall skin roughness by 14%
- Improves skin oxygenation by
754%
- Promotes cell renewal by
25%
VISIFIRM™ is a new face & body treatment that synergistically combines Tri-Peptide technology with a patented delivery system to promote skin respiration and the synthesis of collagen (types I & IV), hyaluronic acid, fibronectin and glycosaminoglycan. The messenger peptides help to stimulate the skin and cell turnover. The end result is a superior clinically proven system that reduces the area of deep wrinkles by 44%, depth of main wrinkles by as much as 39% and overall skin roughness by 14%, while improving skin oxygenation by 754% and promoting cell renewal by 25%.
BOTOX® Cosmetic injections have become the most popular cosmetic treatment for reducing wrinkles. Many cosmetic companies have raced to create topical skin care alternatives that slow or relax muscle activity. But slowing or blocking muscular contraction does not replace the role of tissue regeneration. One popular topical alternative that focuses more on the skin structure is StriVectin-SD, offering strong claims, selling for $135 per tube.
VISIFIRM™ offers the strong claims, but goes further with a self-activating technology, while instantly cooling the skin and signals the patented technology is working. Consumers simply love the sensory action of this technology, while the messenger peptides deliver the longer term benefits.